Intrinsic Value of S&P & Nasdaq Contact Us

CTI BioPharma Corp. CTIC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
31/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.40
+14.3%

CTI BioPharma Corp. (CTIC) has 20 known insider and institutional holders on record. The largest holder is ORBIMED ADVISORS LLC with 7,520,600 shares. Other notable holders include BIANCO JAMES A and Craig Adam R.

CTIC Insider Ownership

Top Holder
ORBIMED ADVISORS LLC
7,520,600 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Orbimed Advisors Llc 10 Percent Owner 7,520,600 2021-01-11
100%
2 Bianco James A Director 2,000,000 2016-10-03
27%
3 Craig Adam R President and CEO 900,000 2023-03-16
12%
4 Bianco Louis A EVP, Finance & Administration 622,933 2016-03-23
8%
5 Gregorian Vartan Director 468,937 2014-03-28
6%
6 Kirske David EVP, Chief Financial Officer 200,000 2023-03-16
3%
7 Fong James K EVP & Chief Commercial Officer 200,000 2023-03-16
3%
8 Hale Jean R Chairman, President & CEO 127,614 2018-01-25
2%
9 Mundinger Mary Oneil Director 100,000 2015-12-31
1%
10 Singer Jack W EVP, Chief Scientific Officer 94,433 2018-05-17
1%
11 Metzger Michael A Director 80,000 2023-04-07
1%
12 Fischer Laurent Director 80,000 2023-04-07
1%
13 Parks Diane L. Director 80,000 2023-04-07
1%
14 Parkinson David Ross Director 80,000 2023-04-07
1%
15 Lampert Mark N Director 80,000 2022-03-11
1%
16 Perry Matthew D Director 80,000 2023-04-07
1%
17 Bvf Partners L P/il 10 Percent Owner 80,000 2023-04-07
1%
18 Tuckson Reed Vaughn Director 80,000 2023-04-07
1%
19 Love Richard L Director 74,694 2017-10-02
1%
20 Bauer John H Director 63,695 2015-09-25
1%

No ownership data available for CTIC.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message